Diets & Weight Loss

Onychomycosis

Fungal infection of the nails causing thickening, splitting, and discoloration

Question: Does Lamisil work well for onychomycosis? I have read some other answers regarding onychomycosis on your toenails but I have it on all 10 fingers. I am going to go to the doctor tomorrow but I was just wondering if anyone has experienced this before? I have researched different types of nail fungus and I recognized that it is onychomycosis. Any info would be helpful. Thanks.

Answer: Lamisil is active against most strains of causing Onychomycosis of the toenail or fingernail: Trichophyton mentagrophytes, Trichophyton rubrum. It may be effective for infections of Microsporum gypseum and M. nanum, Trichophyton verrucosum, Epidermophyton floccosum, Candida albicans, and Scopulariopsis brevicaulis. Dosing - Fingernail: 250 mg/day for up to 6 weeks; toenail: 250 mg/day for 12 weeks; doses may be given in two divided doses Contraindications - Not recommended for use in patients with pre-existing liver or renal disease Talk to your doctor or pharmacist for more information

 


Onychomycosis Related Products and News

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for ...

MarketWatch (press release)
"We are convinced MycoVa(TM) has the potential to be an effective treatment option for patients with mild to moderate onychomycosis," said Bassam Damaj, PhD, President and Chief Executive Officer of Apricus Bio. "We expect this upcoming meeting to ...
 

Anacor Pharmaceuticals Reports First Quarter 2012 Financial Results

MarketWatch (press release)
"Our Phase 3 trials of tavaborole in onychomycosis are progressing well, with retention and compliance rates performing better than our assumptions. We are looking forward to reporting data from our first Phase 3 trial in January 2013," said David ...
 

Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at ...

MarketWatch (press release)
Tavaborole is our lead topical antifungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States. Anacor is currently conducting two Phase 3 ...
 

Dr. John Sigle: Breakthrough treatment for toenail fungus

AugustaGazette.com
Toenail fungus, medically known as onychomycosis, is a problematic condition that can cause both physical and emotional effects. As toenail fungus grows and spreads deeper into the nail, it can cause the nail to swell and become discolored.
 

Apricus Biosciences Announces First Quarter 2012 Financial Results Conference ...

MarketWatch (press release)
Apricus Bio also completed first quarter transactions for MycoVa(TM), the Company's treatment for onychomycosis, with Stellar Pharmaceuticals and Elis Pharmaceuticals, bringing over $10 million in upfront and future potential milestone payments, ...
 

Stinkhorn fairy ring sprouts on No 10 lawn

The Spoof (satire)
The foul-smelling sticky mushroom is notorious in rooting from minute dermatophytic onychomycosis fungal nail spores, spread via dodgy trainers and other people's dirty socks. Commenting on the nauseating stench a No 10 spokeman said the fungus might ...
 

Chicago Tribune

Pay attention to your feet
Chicago Tribune
 

Cynosure Reports Earnings of $0.06 per Share on 56% Increase in Revenues for ...

MarketWatch (press release)
... perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat Onychomycosis.
 

Total recall of unregistered pharmaceutical product Maximum Strength Fungicure ...

7thSpace Interactive (press release)
A DH spokesman revealed that the matter came to light upon the department's investigation into a public enquiry that the Chinese package insert of Fungicure carried the indication "onychomycosis", which was not found in the English package insert, ...
 

Reply Submitted to Pliaglis FDA Complete Response Letter

MarketWatch (press release)
Galderma's extensive product portfolio is available in 70 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical ...